Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses And Other Current Liabilities (Details)

v3.20.2
Accrued Expenses And Other Current Liabilities (Details) - USD ($)
Apr. 24, 2020
Jun. 30, 2020
Dec. 31, 2019
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]      
Research and development expenses   $ 1,899,830 $ 920,901
Compensation and benefits   1,670,669 1,591,964
General and administrative   912,943 360,016
Sales and marketing   212,807 120,056
Sales returns and allowances   1,144,427 2,284,175
Medicaid rebates   101,458 118,271
Lease liability, current   431,543 155,815
Other   113,981 89,054
Total accrued expenses and other current liabilities   6,487,658 $ 5,640,252
Written notice, term 30 days    
Accrued severance $ 800,000 800,000  
Accrued severance costs, term 18 months    
Executive Officer      
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]      
Accrued compensation   $ 300,000